| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 12/30/2014 | US8921520 Removal of serine proteases by treatment with finely divided silicon dioxide |
| 12/30/2014 | US8921393 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases |
| 12/30/2014 | US8921384 Spiro[2.4]heptanes for treatment of flaviviridae infections |
| 12/30/2014 | US8921322 Use of at least one botulinum neurotoxin for treating the pain induced by therapeutic treatments for the AIDS virus |
| 12/30/2014 | US8921316 Stable liquid VEGF antagonist formulations |
| 12/30/2014 | US8921106 Antibodies that bind the glutamate ligand binding region of NOTCH3 |
| 12/30/2014 | US8921101 Attenuated poliovirus |
| 12/30/2014 | US8921071 Targeting poly-gamma-glutamic acid to treat Staphylococcus epidermidis and related infections |
| 12/30/2014 | US8921056 Compositions for diagnosis and therapy of diseases associated with aberrant expression of futrins (R-Spondins) and/or Wnt |
| 12/30/2014 | US8921050 Methods of diagnosing renal cell carcinoma |
| 12/30/2014 | US8920815 Compositions and methods for treatment of microbial infections |
| 12/30/2014 | US8920814 Bacterial endotoxin for the prevention of metabolic disorders and bacterial infections |
| 12/30/2014 | US8920813 Adenoviral vector-based dengue fever vaccine |
| 12/30/2014 | US8920812 Chimeric RSV-F polypeptide and lentivirus or alpha-retrovirus Gag-based VLPS |
| 12/30/2014 | US8920811 Recombinant adenovirus useful for treating malignancy over-expressing proto-oncogene neu/erb B2 |
| 12/30/2014 | US8920809 Chimera comprising bacterial cytotoxin and methods of using the same |
| 12/30/2014 | US8920808 Cytokine-based fusion proteins for treatment of multiple sclerosis |
| 12/30/2014 | US8920807 Vault complexes for cytokine delivery |
| 12/30/2014 | US8920806 Method of modulating inflammatory response by downregulation of activin |
| 12/30/2014 | US8920805 Inhibition of tumor metastasis by anti-neuropilin 2 antibodies |
| 12/30/2014 | US8920804 Methods and materials for the detection of dengue virus infection |
| 12/30/2014 | US8920803 Immunotherapeutic method involving CD123 (IL-3Rα) antibodies and immunostimulating complex |
| 12/30/2014 | US8920802 Methods for the treatment or prevention of systemic sclerosis |
| 12/30/2014 | US8920800 Treatment of cancer with elevated dosages of soluble FGFR1 fusion proteins |
| 12/30/2014 | US8920799 Methods of treating cancer by administering an Axl ligand-binding portion of an Axl tyrosine kinase receptor extracellular domain |
| 12/30/2014 | US8920798 Myostatin binding agents, nucleic acids encoding the same, and methods of treatment |
| 12/30/2014 | US8920797 Highly concentrated stabilized IgM solution |
| 12/30/2014 | US8920776 Compositions and methods for the detection diagnosis and therapy of hematological malignancies |
| 12/30/2014 | US8920774 Drug having regulatory cell ligand contained in liposome |
| 12/30/2014 | CA2704119C Humanized anti-venezuelan equine encephalitis virus recombinant antibodies |
| 12/30/2014 | CA2675847C Pegylated a.beta. fab |
| 12/30/2014 | CA2647985C High titer recombinant influenza viruses for vaccines |
| 12/30/2014 | CA2542239C Multispecific deimmunized cd3-binders |
| 12/30/2014 | CA2477234C Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 12/25/2014 | US20140380515 Transgenic transchromosomal rodents for making human antibodies |
| 12/25/2014 | US20140378669 Methods for conjugation of oligosaccharides or polysaccharides to protein carriers through oxime linkages via 3-deoxy-d-manno-octulsonic acid |
| 12/25/2014 | US20140378666 Dual specificity antibodies and methods of making and using |
| 12/25/2014 | US20140378656 Soluble tcr molecules and methods of use |
| 12/25/2014 | US20140378654 Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors |
| 12/25/2014 | US20140377366 Biodegradable polymers for delivery of therapeutic agents |
| 12/25/2014 | US20140377311 Method of preventing allergies |
| 12/25/2014 | US20140377309 Agonists and antagonists of toll-like receptor (tlr) 13 |
| 12/25/2014 | US20140377308 METHOD FOR PRODUCTION OF pH STABLE ENVELOPED VIRUSES |
| 12/25/2014 | US20140377307 Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities |
| 12/25/2014 | US20140377306 Recombinant vaccine viruses expressing il-15 and methods of using the same |
| 12/25/2014 | US20140377302 Immunogenic composition |
| 12/25/2014 | US20140377300 Tuberculosis Compositions And Methods Of Using The Same |
| 12/25/2014 | US20140377299 Immunotherapy targeting intracellular pathogens |
| 12/25/2014 | US20140377298 Treatment of pigs with pcv2 antigen |
| 12/25/2014 | US20140377296 H3 influenza a virus |
| 12/25/2014 | US20140377293 Methods for treating newly diagnosed multiple myeloma with 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione in combination with dexamethasone |
| 12/25/2014 | US20140377276 Vascular endothelial cell growth factor antagonists |
| 12/25/2014 | US20140377274 Use of 2-deoxy-d-glucose to sensitize cancer cells to an agent that activates the extrinsic apoptotic pathway |
| 12/25/2014 | US20140377265 Anticoagulant antidotes |
| 12/25/2014 | US20140377261 Vaccines against antigens involved in therapy resistance and methods of using same |
| 12/25/2014 | US20140377260 Protective vaccine based on staphylococcus aureus sa2074 protein |
| 12/25/2014 | US20140377259 Methods for inhibiting hiv-1 replication involving the administration of an anti-ccr5 receptor monoclonal antibody and small molecule ccr5 receptor antagonist |
| 12/25/2014 | US20140377258 Treatment Of Cancers Using PI3 Kinase Isoform Modulators |
| 12/25/2014 | US20140377257 Combination therapy for b cell disorders |
| 12/25/2014 | US20140377255 4-1bb binding molecules |
| 12/25/2014 | US20140377254 Subtypes of humanized antibody against interleukin-6 receptor |
| 12/25/2014 | US20140377252 Method for predicting the response to treatment with an her2-blocking agent |
| 12/25/2014 | US20140377251 Formulation for anti-alpha4beta7 antibody |
| 12/25/2014 | US20140377250 Compositions and methods for potentiating immune response, enhancing immunotherapy, and increasing vaccine potency |
| 12/25/2014 | US20140377221 Biomarkers and combination therapies using oncolytic virus and immunomodulation |
| 12/25/2014 | US20140377215 Delivery of therapeutic agents by a collagen binding protein |
| 12/25/2014 | US20140377181 Molecules with extended half-lives, compositions and uses thereof |
| 12/25/2014 | US20140377172 Novel Antibody Recognizing a Small Subset of Human Hematopoietic Cells |
| 12/24/2014 | CN104245738A 针对人tweak和人il17的双特异性抗体及其用途 For people who tweak and il17 bispecific antibodies and their use |
| 12/24/2014 | CN104245733A 针对受体的双重可变结构域免疫球蛋白 For receptor dual variable domain immunoglobulin |
| 12/24/2014 | CN104245732A 拮抗cd40l的抗体多肽 Cd40l antagonistic antibody polypeptides |
| 12/24/2014 | CN104245731A 抗乙型流感病毒的广泛保护性人单克隆抗体及其使用方法 Anti-influenza B virus broad protective human monoclonal antibodies and methods of use |
| 12/24/2014 | CN104245730A 源自血浆的免疫球蛋白的级分i-iv-1沉淀 Plasma-derived immunoglobulin fractions i-iv-1 precipitate |
| 12/24/2014 | CN104244989A 含有新颖前药的分子组合物和其用途 Molecular composition containing the novel prodrugs and their uses |
| 12/24/2014 | CN104244984A 用于治疗剂的方法和组合物 A method for therapeutic agents and compositions |
| 12/24/2014 | CN104244980A 经由FcγIIB促进抗原消除的抗原结合分子 Via FcγIIB promote antigen-binding molecule to eliminate the |
| 12/24/2014 | CN104244979A 使用il-17拮抗剂治疗强直性脊柱炎的方法 Use il-17 antagonist treatment of ankylosing spondylitis method |
| 12/24/2014 | CN104244978A 通过施用丝氨酸蛋白酶抑制剂治疗或预防流感病毒感染的方法 By administering serine protease inhibitors in the treatment or prevention of influenza virus infection |
| 12/24/2014 | CN104244977A Mica结合剂 Mica binders |
| 12/24/2014 | CN104244976A 佐剂化合物 Adjuvant compound |
| 12/24/2014 | CN104244975A 用于制备树突细胞疫苗的方法 Methods for preparation of dendritic cell vaccine |
| 12/24/2014 | CN104244974A 亨德拉和尼帕病毒g糖蛋白免疫原性组合物 Hendra and Nipah virus glycoprotein g immunogenic compositions |
| 12/24/2014 | CN104244973A 针对口蹄疫(fmd)的基于合成肽的紧急疫苗 For foot and mouth disease (fmd) synthetic peptide-based vaccines for emergency |
| 12/24/2014 | CN104244972A Lps疫苗 Lps vaccine |
| 12/24/2014 | CN104244971A 抗疟疾微颗粒疫苗 Microparticle vaccine against malaria |
| 12/24/2014 | CN104244970A 用于向动物或人体无创输送活性蛋白质的制剂 Formulations for animal or human to non-invasive delivery of active proteins |
| 12/24/2014 | CN104244940A 减少胃肠道的弯曲杆菌定植 Reducing the Campylobacter colonization of the gastrointestinal tract |
| 12/24/2014 | CN104244929A 用于调节免疫反应的介孔二氧化硅组合物 Mesoporous silica composition for modulating the immune response |
| 12/24/2014 | CN104232732A Mapk信号整合激酶2在治疗动脉粥样硬化中的功能和应用 Mapk signal integrity kinase 2 functions and applications in the treatment of atherosclerosis in |
| 12/24/2014 | CN104232677A 表达mage3的疟原虫减毒子孢子构建方法及其应用和抗肺癌疫苗 Expression attenuated Plasmodium sporozoites mage3 construction method and its application and anti-cancer vaccine |
| 12/24/2014 | CN104232662A 小附红细胞体mpg1基因、蛋白及应用 Small Eperythrozoon mpg1 gene, protein and application |
| 12/24/2014 | CN104232661A 重组dna序列、酵母菌、乙肝表面抗原制备方法及疫苗 Recombinant dna sequence, yeast, hepatitis B surface antigen preparation methods and vaccines |
| 12/24/2014 | CN104232650A 特发性基底节钙化新的致病基因及其编码蛋白质和应用 Idiopathic basal ganglia calcification new virulence genes and their encoded proteins and application |
| 12/24/2014 | CN104232594A 重组类禽型h1n1流感病毒灭活疫苗株(js40/pr8)及其制备方法和应用 Restructuring h1n1 avian influenza virus type inactivated vaccine strain (js40 / pr8) and its preparation method and application |
| 12/24/2014 | CN104232592A 一种鸡传染性支气管炎病毒451株及其应用 One kind of avian infectious bronchitis virus and its applications 451 |
| 12/24/2014 | CN104232590A 一种卵泡抑素样蛋白1的单克隆抗体及其应用 A follistatin-like protein 1 monoclonal antibody and its application in |
| 12/24/2014 | CN104232576A 蛋白-细胞偶联物、其制备方法和用途 Protein - cell conjugates, their preparation and use |
| 12/24/2014 | CN104232564A 一种st细胞制备猪瘟疫苗的培养基及其使用方法 One kind of culture and classical swine fever vaccine prepared using cell st |
| 12/24/2014 | CN104232535A 鰤鱼诺卡氏菌诱变弱毒株及其应用 Yellowtail attenuated strain of Nocardia Mutation and Its Applications |
| 12/24/2014 | CN104232502A 维罗纳气单胞菌菌蜕、其制备方法及应用 Verona Aeromonas bacteria shed, its preparation method and application |